Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24
Published July 3, 2024 · Recall initiated: May 20, 2024
Summary
FDA records drug Class II recall D-0565-2024, published July 3, 2024 and initiated May 20, 2024. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 220,400 cartridges; Lot: Lot#: HJ7566; Exp 2025/05 Lot#: HN8747; Exp 2025/09 Lot#: HN8749; Exp 2025/09. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
What to do
Voluntary: Firm initiated · Letter
Get an email if LABETALOL HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LABETALOL HYDROCHLORIDE
- Manufacturer
- Pfizer Inc.
- Distributor
- US Nationwide and Puerto Rico.
- Lot
- Lot#: HJ7566; Exp 2025/05 Lot#: HN8747; Exp 2025/09 Lot#: HN8749; Exp 2025/09
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABuprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit withJuly 3, 2024
- FDAExtra Strength Acetaminophen 500 MG Tablets,100-count Bottle, Distributed By: MAJOR PHARMACEUTICALS, 17177 NJuly 3, 2024
- FDAProgesterone 200 mg, Compounded, 90-count bottle, Rx, Dissolve One Sublingual Tablet After Dinner Nightly,July 3, 2024
- FDAZilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only,July 3, 2024
- FDALabetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a)March 14, 2018
- FDALabetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glassJuly 16, 2014
Questions about this recall
Was Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24 recalled?
Yes. FDA published recall D-0565-2024 on July 3, 2024. Reported hazard: Lack of Assurance of Sterility-The potential for incomplete crimp seals.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LABETALOL HYDROCHLORIDE.